低灌注症状对椎基底动脉疾病血流动力学受损及卒中风险的预测价值较差
VERiTAS前瞻性观察研究纳入72例近期椎基底动脉TIA或卒中且椎/基底动脉狭窄≥50%或闭塞患者,66例有低灌注症状数据。定量MRA显示正常血流43例、低/临界血流23例,两组低灌注症状比例无显著差异(11.6% vs 13.0%,P=0.99)。低灌注症状对低/临界血流的阳性预测值为37.5%、阴性预测值为65.5%,且与后续卒中风险无关(P=0.87)。
要点
- 低灌注症状与定量MRA评估的血流动力学受损相关性差,不能作为血流测量的可靠替代指标。
- 低灌注症状对低/临界血流的阳性预测值37.5%、阴性预测值65.5%。
- 低灌注症状与后续卒中风险无关(P=0.87),而血流状态可强烈预测卒中风险。
核心结论
- 低灌注症状单独与定量MRA评估的实际血流动力学受损及后续卒中风险相关性差,不是血流测量的可靠替代指标。
研究设计与样本
- 前瞻性观察性VERiTAS研究(椎基底动脉血流评估与短暂性脑缺血发作和卒中风险研究),纳入近期椎基底动脉TIA或卒中且椎动脉或基底动脉动脉粥样硬化性狭窄≥50%或闭塞的患者。
- 共纳入72例受试者,其中66例有低灌注症状数据。
- 使用定量磁共振血管造影测量椎基底动脉大血管血流,根据远端供血区区域血流并纳入侧支代偿能力,将患者分为低流量、临界流量或正常流量。
- 评估合格事件低灌注症状(定义为与体位改变、用力或劳累相关的症状,或近期降压药物调整)与定量血流状态(正常 vs 临界/低)的关系,并分析其作为后续卒中风险预测因素的价值。
主要发现
- 初始定量MRA分类:43例为正常血流,23例为低流量(n=16)或临界流量(n=7)。
- 正常血流组5例(11.6%)和低/临界血流组3例(13.0%)报告至少一项合格事件低灌注症状(P=0.99,Fisher精确检验)。
- 低灌注症状对低/临界血流状态的阳性预测值为37.5%,阴性预测值为65.5%。
- 与血流状态强烈预测后续卒中风险相比,低灌注症状与卒中结局无关(P=0.87,对数秩检验)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Cerebral hypoperfusion symptoms (defined as symptoms related to change in position, effort or exertion, or recent change in antihypertensive medication) have been used in stroke studies as a surrogate for detecting hemodynamic compromise. However, the validity of these symptoms in identifying flow compromise in patients has not been well established. We examined whether hypoperfusion symptoms correlated with quantitative measurements of flow compromise in the prospective, observational VERiTAS study (Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke). Methods- VERiTAS enrolled patients with recent vertebrobasilar transient ischemic attack or stroke and ≥50% atherosclerotic stenosis or occlusion in vertebral or basilar arteries. Hemodynamic status using vertebrobasilar large vessel flow was measured using quantitative magnetic resonance angiography, and patients were designated as low, borderline, or normal flow based on distal territory regional flow, incorporating collateral capacity. The presence of qualifying event hypoperfusion symptoms was assessed relative to the quantitatively determined flow status (normal versus borderline/low) and also examined as a predictor of subsequent stroke risk. Results- Of the 72 enrolled subjects, 66 had data on hypoperfusion symptoms available. On initial quantitative magnetic resonance angiography designation, 43 subjects were designated as normal flow versus 23 subjects designated as low flow (n=16) or borderline flow (n=7). Of these, 5 (11.6%) normal flow and 3 (13.0%) low/borderline flow subjects reported at least one qualifying event hypoperfusion symptom ( P=0.99, Fisher exact test). Hypoperfusion symptoms had a positive predictive value of 37.5% and negative predictive value of 65.5% for low/borderline flow status. Compared with flow status, which strongly predicted subsequent stroke risk, hypoperfusion symptoms were not associated with stroke outcome ( P=0.87, log-rank test). Conclusions- These results suggest that hypoperfusion symptoms alone correlate poorly with actual hemodynamic compromise as assessed by quantitative magnetic resonance angiography and subsequent stroke risk in vertebrobasilar disease, and are not a reliable surrogate for flow measurement. Clinical Trial Registration- URL: https://www.clinicaltrials.gov . Unique identifier: NCT00590980.
引用
- Amin-Hanjani S, Stapleton CJ, Du X, et al. Hypoperfusion Symptoms Poorly Predict Hemodynamic Compromise and Stroke Risk in Vertebrobasilar Disease. Stroke. 2019. PMID: 30580717. doi:10.1161/STROKEAHA.118.023101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。